Related Experiment Videos
Presentation of mucopolysaccharidosis VII (beta-glucuronidase deficiency) in infancy
Insights
Mucopolysaccharidosis VII (beta-glucuronidase deficiency) can be recognized in newborns, unlike other forms. This infantile onset disorder is linked to moderate, non-progressive intellectual disability.
Area of Science:
- Genetics
- Biochemistry
- Pediatrics
Background:
- Mucopolysaccharidoses (MPS) are a group of rare genetic disorders.
- MPS VII, or beta-glucuronidase deficiency, is a lysosomal storage disease.
- The infantile onset form of MPS VII has a significant impact on development.
Observation:
- A case of infantile onset mucopolysaccharidosis VII is presented.
- This patient displayed neonatal presentation, progressive joint contractures, and hydrocephalus.
- These features were previously unrecognized in MPS VII.
Findings:
- Mucopolysaccharidosis VII is clinically recognizable at birth.
- Unlike other MPS, MPS VII presents early with distinct features.
- Moderate, non-progressive intellectual deficiency is a key characteristic.
Implications:
- Early diagnosis of MPS VII is possible through neonatal recognition.
- Understanding these features aids in timely intervention and management.
- Further research into MPS VII pathogenesis and treatment is warranted.
Abstract:
A child is presented with mucopolysaccharidosis VII (beta-glucuronidase deficiency), bringing to six the number of reported patients with the infantile onset form of this disorder. This patient exhibited the following features, previously unrecognised as part of this syndrome: presentation in the neonatal period, progressive joint contractures, and hydrocephalus. This child's course and data from published reports indicate that mucopolysaccharidosis VII, unlike the other known mucopolysaccharidoses, is clinically recognisable in the newborn period and is most likely to be associated with moderate mental deficiency which does not progress over time.